Insider Trading History of Mirabelli Christopher

The following table details the insider trading activities (stock purchases, stock sales, and stock option exercises) of Mirabelli Christopher since 2005. This trader's CIK number is 1262326. At the time of last reporting, Mirabelli Christopher was the Chairman of the Board of Leap Therapeutics, Inc.. (stock ticker symbol LPTX). Also see all insider trading activities at Leap Therapeutics, Inc..

Note that in the past Mirabelli Christopher also reported insider trading activities as an insider of the following companies:

Yearly summary of insider trading at Critical Therapeutics Inc (CRTX) by Mirabelli Christopher

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2005 CRTX 1,094,891 $6,000,002 0 $0 0 $0

Yearly summary of insider trading at Leap Therapeutics, Inc. (LPTX) by Mirabelli Christopher

Insider Buying Insider Sales Option Exercises
Year Symbol Shares Value Shares Value Shares Value
2025 LPTX 0 $0 0 $0 22,500 $0
2024 LPTX 0 $0 0 $0 5,000 $0
2019 LPTX 571,428 $999,999 0 $0 0 $0
2017 LPTX 1,057,769 $6,436,524 0 $0 0 $0


Insider trading activities at 2 companies by Mirabelli Christopher:

1. Critical Therapeutics Inc (CRTX)

2. Leap Therapeutics, Inc. (LPTX)

Table 1. Insider trading of Critical Therapeutics Inc (CRTX) by Mirabelli Christopher

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2005-06-20 CRTX Buy 1,094,891 5.48 6,000,002

Table 2. Insider trading of Leap Therapeutics, Inc. (LPTX) by Mirabelli Christopher

Trade Date Symbol Trade Type Shares Price ($) Value ($)
2025-03-28 LPTX Option Ex 22,500 .00 0
2024-01-26 LPTX Option Ex 5,000 .00 0
2019-02-05 LPTX Buy 571,428 1.75 999,999
2017-11-14 LPTX Buy 1,057,769 6.08 6,436,524

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Mirabelli Christopher (Chairman of the Board of Leap Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.